Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Specialty Drug Distribution Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing specialty drug development pipeline and trade
5.1.1.2. Emphasis on drug cost, supply, and storage optimization to offer patient-centric care
5.1.2. Restraints
5.1.2.1. Complexity in managing different distribution channels
5.1.3. Opportunities
5.1.3.1. New technology integration and advancements in specialty drug distribution
5.1.3.2. Rising expansion of specialty pharmacies worldwide
5.1.4. Challenges
5.1.4.1. Changing regulatory frameworks associated with specialty drug handling
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.3.1. Introduction of new digital ecosystems focusing on improving the distribution of specialty drugs in the Americas
5.3.2. Focus on specialty drug distribution network expansion in the Asia-Pacific region
5.3.3. Government initiatives for rare disease management and well-established pharma companies expand the market growth
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
5.10.1. Clinical Trials & Drug Development Pipeline
5.10.2. Speciality Drug Distribution Ecosystem

6. Specialty Drug Distribution Market, by Disease Indication
6.1. Introduction
6.2. AIDS
6.3. Hemophilia
6.4. Multiple Sclerosis
6.5. Oncology
6.6. Rheumatoid Arthritis

7. Specialty Drug Distribution Market, by Distributor Type
7.1. Introduction
7.2. Full line Wholesalers
7.3. Specialty Distributors

8. Specialty Drug Distribution Market, by Distribution Type
8.1. Introduction
8.2. Hospitals & Clinic Pharmacies
8.3. Independent Pharmacies
8.4. Large Chain Pharmacies
8.5. Mail-Order Pharmacies
8.6. Online Stores
8.7. Specialty Pharmacies

9. Specialty Drug Distribution Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Healthcare Payers
9.4. Home Settings
9.5. Hospital & Clinics

10. Americas Specialty Drug Distribution Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Specialty Drug Distribution Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Specialty Drug Distribution Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Elevance Health Announces Closing of BioPlus Acquisition
13.3.1.2. CVS Health to acquire Oak Street Health
13.3.1.3. Prime Therapeutics closes USD 1.35 billion Magellan Rx acquisition, uniting pharmacy and medical drug management expertise
13.3.1.4. Halozyme to Acquire Antares Pharma for around USD 960 million
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary to Accelerate the Commercialization of XERAVA in Mainland China
13.3.2.2. Shields Health Solutions and MyMichigan Health Partner to Enhance Specialty Pharmacy Services for Patients and Families
13.3.2.3. Shields Health Solutions Expands Nationwide Partnerships to Enhance Specialty Pharmacy Services
13.3.2.4. Manulife and Shoppers Drug Mart collaborate to help manage serious medical conditions
13.3.3. New Product Launch & Enhancement
13.3.3.1. McKesson Canada Launches New Digital Ecosystem to Simplify and Enhance Specialty Patient Outcomes
13.3.4. Award, Recognition, & Expansion
13.3.4.1. Cardinal Health Continues to Expand at-Home Solutions Business

14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Aark Pharmaceuticals
14.1.2. Accredo Health Group, Inc.
14.1.3. AmerisourceBergen Corporation
14.1.4. BioCare, Inc.
14.1.5. Cardinal Health, Inc.
14.1.6. Centene Corporation
14.1.7. China National Pharmaceutical Group Corporation
14.1.8. CVS Specialty, Inc.
14.1.9. Elevance Health, Inc.
14.1.10. Eversana
14.1.11. Feron Healthcare Pvt Ltd.
14.1.12. Kroger Specialty Pharmacy
14.1.13. Lifeline Pharmaceuticals, LLC
14.1.14. McKesson Corporation
14.1.15. Medipal Holdings Corporation
14.1.16. Morris & Dickson Co., LLC
14.1.17. Optum, Inc.
14.1.18. PHOENIX Pharmahandel GmbH & Co KG
14.1.19. Shanghai Pharmaceuticals Group Co., Ltd.
14.1.20. Shields Health Solutions Holdings, LLC
14.1.21. Sun Pharmaceutical Industries Limited
14.1.22. Suzuken Co., Ltd.
14.1.23. Teva Pharmaceutical Industries Ltd.
14.1.24. Walmart Inc.
14.2. Key Product Portfolio

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing



List of Figures

FIGURE 1. SPECIALTY DRUG DISTRIBUTION MARKET RESEARCH PROCESS
FIGURE 2. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2022 VS 2030
FIGURE 3. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. SPECIALTY DRUG DISTRIBUTION MARKET DYNAMICS
FIGURE 7. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2022 VS 2030 (%)
FIGURE 8. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2022 VS 2030 (%)
FIGURE 10. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2022 VS 2030 (%)
FIGURE 12. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 14. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. SPECIALTY DRUG DISTRIBUTION MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. SPECIALTY DRUG DISTRIBUTION MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. SPECIALTY DRUG DISTRIBUTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 6. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 12. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 15. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CLINIC PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL-ORDER PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 40. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 62. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 63. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 64. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 66. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 68. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 74. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 75. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 76. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 98. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 99. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 100. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 111. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 115. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 117. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 119. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 120. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 121. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 123. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 125. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 127. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 135. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 137. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 147. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 148. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 149. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 151. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 152. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 153. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 155. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 156. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 157. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 171. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 173. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. TURKEY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 183. TURKEY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 184. TURKEY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 185. TURKEY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. SPECIALTY DRUG DISTRIBUTION MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 195. SPECIALTY DRUG DISTRIBUTION MARKET SHARE, BY KEY PLAYER, 2022
TABLE 196. SPECIALTY DRUG DISTRIBUTION MARKET LICENSE & PRICING